4-Amino-2-fluoronicotinic acid, 98%, 100mg

4,5,6,7-Tetrahydro-1H-indole, 95.0%, 10g

(1S,3S)-Cyclohexane-1,3-dicarboxylic acid, 97%, 250mg

2-{[4-(methylsulfonyl)phenyl]amino}-1,3-thiazole-4-carboxylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 2.00 µm, 1 Piece(s)

{[5-(2-furyl)-3-isoxazolyl]methyl}amine hydrochloride, 95.0%, 1g

3-Bromo-5-nitroanisole>98.0%(GC)5g

5-(4-Chloro-phenyl)-1H-pyrazole-3-carboxylic acid methyl ester, 98.0%, 5g

3-Chloro-2-methylthiophene, 95%, 250mg

2,3-Dibromo-5-methylpyridine, 98.0%, 25g

5-BROMO-6-CHLORO-4(3H)-PYRIMIDINONE, 95%, 1g

Methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, 97%, 10g

1-(tert-Butyl) 2-methyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-1,2-dicarboxylate, 95+%, 250mg